A significant reduction of TRPM3 surface expression was reported on NK cells in ME/CFS patients compared with HC along with a reduction in cytoplasmic Ca2+ in response to Ca2+ modulators. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.